Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-27 @ 12:28 PM
Study NCT ID:
NCT00391534
Status:
TERMINATED
Last Update Posted:
2010-04-15
First Post:
2006-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Sponsor:
Desitin Arzneimittel GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OXC-039/K
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Martina Wangemann
Old Organization:
Desitin Arzneimittel GmbH
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |